Skip to main navigation Skip to main content

Webinar

The National Lung Cancer Screening Program: What GPs need to know Members login for free access About RACGP online events

Details

Type: Webinar
3 Jun, 7:30 PM - 8:30 PM (AEST)

Contact

For more information:
Email: NSW&ACT Facutly
Call: 02 9886 4700

Price

RACGP Members: Free
Non-Members: Free

Free registration

The National Lung Cancer Screening Program: What GPs need to know

Webinar 3 Jun, 7:30 PM - 8:30 PM (AEST)

Join our National Lung Cancer Screening Program webinar 
 
Launching in July 2025, the National Lung Cancer Screening Program (NLCSP) will offer free low-dose CT scans to people aged 50-70 years with a referral from their general practitioner.  
 
The NLCSP is the first new screening program in 20 years and presents a significant opportunity to detect cancer earlier, enhance treatment options and improve outcomes for one of the deadliest cancers in NSW. 
 
It will focus on the early detection of lung cancer in high-risk individuals with a smoking history who have no symptoms. 
 
General practitioners are essential to the success of this program. We encourage you to prepare now by identify eligible patients in your practice software, promoting the NLCSP and making referrals from July 2025. 
 

Learning outcomes

  1. Understand your role in the National Lung Cancer Screening Program: Enabling identification of eligibility and assess suitability for screening.
  2. Communicate effectively with patients about lung cancer screening: Support shared decision-making by discussing program benefits, early detection importance, risks and benefits and addressing patient concerns
  3. Manage screening results and follow-up care: support ongoing screening surveillance and or coordinate follow-up investigations relating to lung and or additional actionable findings.
  4. Gain awareness of National Cancer Screening Register interface: Learn to effectively utilise results, reports, and reminders to enhance patient engagement and support in clinical practice.

Speakers

Dr Kerry Hancock
Chair RACGP Specific Interests Respiratory Medicine

Dr Kerry Hancock is a GP with over 38 years experience in clinical practice with most of that time as a principal of a self-established practice in Adelaide. Dr Hancock’s active participation with respiratory organisations, government health services, research activities, and the RACGP has enabled her to be involved in the development of national primary care-focused respiratory management guidelines, educational activities, and the development and promulgation of tools to assist GPs, practice nurses and pharmacists in the management of their patients with respiratory and related disorders. She is Chair RACGP Specific Interests Respiratory Medicine, Chair Lung Foundation Australia (LFA) Primary Care Clinical Council, member LFA Clinical and Research Council and COPD Clinical Advisory Committee, Honorary Fellow Allergy and Lung Health Unit Melbourne School of Population and Global Health The University of Melbourne, previous Principal Medical Officer and Board member / Director Asthma Foundation SA and previous Chair GP Asthma Group National Asthma Council.

Professor Samantha Ellis
Thoracic Radiologist

Samantha is a thoracic radiologist and Head of thoracic imaging at the Alfred Hospital Melbourne. She is an executive member of ANZSTR (Australian and New Zealand Society of Thoracic Radiology), a special interest group within the college of Radiologists, and a Steering committee member of the LCS working group within RANZCR. Over the last 18 months this working group have worked tirelessly alongside RANZCR, DOHAC, Cancer Australia and many other stakeholders to develop a robust nationwide LCS program.

Dorota Gertig
Medical Director of the National Cancer Screening Register (NCSR)

Since July 2016, Dorota has been the Medical Director of the National Cancer Screening Register (NCSR), playing a key role in implementation and operations of the Register. She is a public health physician and epidemiologist who completed her medical training at Monash University and has a Doctorate in Epidemiology from the Harvard School of Public Health. Professor Gertig was previously the Medical Director of the Victorian Cervical Cytology Registry and the inaugural Medical Director of NHVPR. She is a respected leader in cancer screening and a member of several key national and state committees on cervical screening, including the National Quality and Safety Monitoring Committee for the National Cervical Screening Program. Professor Gertig has an international profile in cancer research, including the epidemiology of cervical, breast and ovarian cancers. With more than 120 scientific publications, her primary research focus is on policy relevant research as well as improving participation in cancer screening.

Disclaimer

  1. The RACGP reserves the right and has sole discretion for any reason and at any time to:
  1. Change the date, location, format, timing and/or any other aspect of an event;
  2. Postpone Events in full or any part of those Events; and/or
  3. Cancel an Event in full or any part. Should this occur, RACGP will issue a notification of change via our website, social media and/or electronic communications. Unless specifically permitted by RACGP’s Delegate Terms and Conditions, RACGP will not be liable for any damages, costs, losses or expenses of any kind incurred or suffered in connection with the RACGP modifying, postponing or cancelling an Event or any part. Please refer to our Delegate Terms and Conditions for further information

Advertising

© 2025 The Royal Australian College of General Practitioners (RACGP) ABN 34 000 223 807